TITLE

THE COMBINED USE OF UROKINASE AND GLYCOPROTEIN IIB/IIIA-TARGETED MICROBUBBLES RECANALIZE RABBIT FEMORAL ARTERY WITH THROMBOTIC OCCLUSIONS

PUB. DATE
October 2010
SOURCE
Heart;Oct2010 Supplement, pA211
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "The Combined Use of Urokinase and Glycoprotein IIB/IIIA-Targeted Microbubbles Recanalize Rabbit Femoral Artery With Thrombotic Occlusions" by Yu-ming Mu and colleagues is presented.
ACCESSION #
66246113

 

Related Articles

  • THE COMBINED USE OF UROKINASE AND GLYCOPROTEIN IIB/IIIA-TARGETED MICROBUBBLES RECANALIZE RABBIT FEMORAL ARTERY WITH THROMBOTIC OCCLUSIONS.  // Heart;Oct2010 Supplement, pA215 

    An abstract of the article "The Combined Use of Urokinase and Glycoprotein IIB/IIIA-Targeted Microbubbles Recanalize Rabbit Femoral Artery With Thrombotic Occlusions" by Yuming Mu is presented.

  • Plasma Levels of Soluble Urokinase-Type Plasminogen Activator Receptor Associate with the Clinical Severity of Acute Puumala Hantavirus Infection. Outinen, Tuula K.; Tervo, Laura; Mäkelä, Satu; Huttunen, Reetta; Mäenpää, Niina; Huhtala, Heini; Vaheri, Antti; Mustonen, Jukka; Aittoniemi, Janne // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Objectives: Urokinase-type plasminogen activator receptor is a multifunctional glycoprotein, the expression of which is increased during inflammation. It is known to bind to β3-integrins, which are elementary for the cellular entry of hantaviruses. Plasma soluble form of the receptor (suPAR)...

  • Extracellular Matrix Biomarker, Fibulin-1, Is Closely Related to NT-proBNP and Soluble Urokinase Plasminogen Activator Receptor in Patients with Aortic Valve Stenosis (The SEAS Study). Kruger, Ruan; Rasmussen, Lars M.; Argraves, William S.; Eugen-Olsen, Jesper; Nielsen, Olav W.; Blyme, Adam; Willenheimer, Ronnie; Wachtell, Kristian; Olsen, Michael H. // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Background: Fibulin-1, a circulating extracellular matrix glycoprotein, has been associated with arterial disease and elevated N-terminal prohormone B-type natriuretic peptide (NT-proBNP) in diabetes. Soluble urokinase plasminogen activator receptor (suPAR), a marker of inflammation, has been...

  • Urokinase expression in transduced endothelial cells. Townsend, Laurace E.; Glover, John L. // American Surgeon;Aug96, Vol. 62 Issue 8, p619 

    Evaluates the expression of urokinase from the transduction of endothelium with a retrovirus containing the gene for a human preprourokinase. Dog surgery; Immunocytochemistry; Immunoassay for human urokinase; Activity assay for urokinase.

  • Urokinase Receptor and Integrin Interactions. Kugler, Matthias C.; Ying Wei; Chapman, Harold A. // Current Pharmaceutical Design;Jul2003, Vol. 9 Issue 19, p1565 

    Urokinase receptors (uPAR) were initially thought to function simply as a mechanism to concentrate the urokinase / plasmin system toward the cell surface. However, extensive evidence has accumulated that this glycolipidanchored receptor also functions in both the adhesive and signaling pathways...

  • Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator. Rockway, Todd W.; Giranda, Vincent L. // Current Pharmaceutical Design;Jul2003, Vol. 9 Issue 19, p1483 

    Urokinase type plasminogen activator (uPA) activates plasminogen to plasmin and is often associated with diseases where tissue remodeling is essential (e.g. cancer, macular degeneration, atherosclerosis). We discuss some of the mechanisms of uPA action in diseases, and evidence that some of the...

  • The Authors Reply:. Huang, Jing; Zhao, Ming-hui // Kidney International;Mar2014, Vol. 85 Issue 3, p711 

    A response from the author of the article related to soluble urokinase receptor (suPAR) in focal segmental glomerulosclerosis in the previous issue is presented.

  • An FDA warning on Abbokinase. Cerrato, Paul L. // RN;May99, Vol. 62 Issue 5, p102 

    Reports on the warning issued by the United States Federal Drug Administration on the risk of infection in patients using the Abbokinase brand of urokinase.

  • Urokinase.  // Reactions Weekly;3/13/2010, Issue 1292, p36 

    The article describes the case of a 67-year-old woman who experienced rebleeding from a verterbral artery dissecting aneurysm following administration of intrathecal urokinase.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics